Spectrum Pharmaceuticals (SPPI) PT Lowered to $4 at H.C. Wainwright
Tweet
Share
E-mail
Get Alerts SPPI Hot Sheet
Price: $1.03 --0%
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
H.C. Wainwright analyst Edward White lowered the price target on Spectrum Pharmaceuticals (NASDAQ: SPPI) to $4.00 (from $6.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Merit Medical Systems, Inc. (MMSI) PT Raised to $97 at BofA Securities
- Square Enix Holdings (9684:JP) (SQNNY) PT Raised to JPY2,950 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
